查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1848743

膜式氧合器市场按类型、应用、最终用户、材料、流量配置和温度划分 - 全球预测 2025-2032

Membrane Oxygenators Market by Type, Application, End User, Material, Flow Configuration, Temperature - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，膜式氧合器市场规模将达到 11.1433 亿美元，年复合成长率为 6.77%。

关键市场统计数据
基准年 2024 6.5981亿美元
预计年份：2025年 7.0416亿美元
预测年份 2032 11.1433亿美元
复合年增长率 (%) 6.77%

为膜式氧合器提供全面的发展方向，重点关注临床需求、技术支援、监管压力以及产业相关人员的策略重点。

膜式氧合器是体外生命维持和外科灌注的基石技术，作为血液气体交换接口，在心肺体外迴圈）过程中维持氧合和二氧化碳清除。其设计、材质以及与监测系统的整合不仅决定了其临床性能，还决定了其在重症监护环境下的可处置性、生物相容性和易用性。随着临床实务朝向更复杂的重症加护应用和门诊外科介入发展，氧合器的可靠性和可预测性对患者预后仍然至关重要。

临床医师越来越倾向选择兼顾生理性能和操作效率的医疗器材。这促使膜几何、纤维製造和表面化学技术同步发展，旨在降低溶血、补体活化和血栓形成风险，同时维持较低的跨膜压力梯度。同时，监管机构对一次性医疗器材、无菌验证和人因工程的要求也促使产品研发更加重视关键环节。综上所述，这些技术和临床驱动因素构成了本执行摘要的其余部分，并为製造、采购和临床应用等各环节的策略决策奠定了基础。

材料创新、设备小型化、数位整合和临床护理分散化如何重新定义膜式氧气疗法的设计、製造和采购标准

在临床需求、材料科学和系统整合的推动下，膜式氧合器领域正经历着变革性的转变。中空纤维结构结合先进的聚甲基戊烯膜和精密的表面涂层，已取代以往的平板式结构，成为高性能体外循环支援的理想选择，显着提高了气体交换效率和血液相容性。同时，製造流程和灭菌技术的进步，使得一次性氧合器的规模化生产成为可能，不仅满足了严格的无菌性和可追溯性要求，也简化了手术室的物流。

同时，这些医疗设备的临床应用环境正变得日益分散。体外膜氧合（ECMO）在非传统医疗环境中的日益普及、进行复杂手术的门诊手术中心不断扩张，以及对模拟和照护现场诊断的日益依赖，都促使市场需求转向更模组化、更易于使用且整合监测功能的设备。数位医疗技术的整合，包括即时感测器远端检测和决策支援演算法，正在提升临床医生调整治疗方案和预防併发症的能力。虽然永续性已不再是首要考虑因素，但其重要性却与日俱增，製造商们正在评估产品生命週期的影响，并探索可回收包装、减少材料用量和减少生产废弃物等方法。这些转变共同重塑了产品开发蓝图、市场推广策略以及买家评估产品价值的标准。

分析2025年美国预期关税调整对膜式氧合器相关人员的供应链、采购和创新的累积影响

美国预计2025年的贸易政策变化和关税调整将对膜式氧合器的供应链、筹资策略和定价动态产生重大影响。许多氧合器组件和高精度製造投入都来自跨境供应链，进口原材料、聚合物树脂或成品的关税增加可能会提高製造商和下游买家的到岸成本。此类变化往往会促使供应商和原始设备製造商（OEM）重新评估筹资策略策略，加快对国内或近岸合作伙伴的供应商资质认证，并考虑建立本地库存缓衝，以在贸易环境波动的情况下维持供应的连续性。

关税带来的成本压力累积效应通常表现为新产品上市延迟和短期内更保守的库存管理，因为製造商优先考虑利润率保护和供应安全。一些缓解策略是可行的：例如，实现供应商；寻找既能保持临床性能又能改善关税待遇的替代材料；以及在关税优惠地区实施製造外包安排。对于供应商，更长的采购前置作业时间和重新评估的总拥有成本计算要求他们更加重视供应商的透明度和协作预测。最终，贸易政策正在加速企业在垂直整合、供应商合作和设计选择方面的策略决策，这些决策能够在维持临床绩效标准的同时降低进口关税的风险。

主导细分市场的洞察揭示了设备架构、临床应用、终端用户需求、材料科学、流动配置和热处理通讯协定如何相互交织，从而指导产品策略。

深入的市场区隔揭示了产品特性、临床应用案例和组织采购优先顺序如何交织，共同塑造需求和创新路径。平板式设计在特定的实验室研究和特殊低流量应用场景中保持着独特的适用性，而中空纤维结构则在临床体外应用中占据主导地位，因为在这些应用中，表面积体积比和紧凑的外形规格至关重要。依应用领域划分，本文探讨了血液氧合（研究）、心肺体外迴圈和体外膜氧合（ECMO）的应用。心肺体外迴圈也进一步扩展到冠状动脉绕道手术绕道手术和瓣膜置换术，这两种手术都呈现出不同的灌注时间曲线和抗凝血管理挑战。

终端用户细分揭示了不同的采购驱动因素。门诊手术中心、医院和研究机构分别从成本效益、临床稳健性和实验灵活性三个方面评估氧气输送装置。按材料划分，目前正在研究聚甲基戊烯、聚丙烯和聚砜，其中聚甲基戊烯因其优异的气体渗透性和热稳定性，在长期体外支持方面越来越受欢迎。流动配置分析考虑了封闭式和开放式系统。闭合迴路设计优先考虑感染控制和精确的气体交换控制，而开放式配置则优先考虑特定手术流程中的简单性和易用性。基于温度的细分考察了低温和常温应用场景，认识到膜性能和血液相容性可能随温度变化而变化，并且安装验证必须解决这些临床方案之间的生物物理差异。总而言之，这些细分视角为设计权衡、监管策略和有针对性的商业化方法提供了基础。

区域临床应用、监管差异和生产能力决定了美洲、欧洲、中东和非洲以及亚太地区膜式氧合器业务的差异化策略。

区域差异对临床实践、监管路径和采购框架的影响，对製造商和医疗保健系统都至关重要。在美洲，体外疗法的临床应用受到以下因素的影响：集中化的体外治疗卓越中心、强调上市后监测和器械可追溯性的法规环境，以及兼顾国内生产和战略进口的供应链。这些动态为那些能够展示可靠的临床数据、可扩展的生产能力和灵活的服务模式的公司创造了机会。

在欧洲、中东和非洲，监管环境复杂多样，各国在努力协调监管环境的同时，采购规范也各不相同，报销政策和医院竞标流程也存在差异，因此需要灵活的商业化模式和强大的临床营运支援。本地製造伙伴关係和分销商关係往往决定产品上市的速度。在亚太地区，部分都市区的临床应用正在快速普及，这催生了一批又一批本地製造商和委託製造製造商，他们能够在前置作业时间和成本方面展开竞争。战略伙伴关係、技术转移协议以及区域性监管策略对于驾驭这种多元化的市场环境，并使产品系列与区域临床和经济优先事项保持一致至关重要。

膜式氧合器供应商之间的竞争与伙伴关係动态，重点在于材料创新、智慧财产权定位、生产规模化与服务差异化。

膜式氧合器的竞争格局由纯粹的製造商、大型医疗设备原始设备製造商 (OEM) 和灵活的契约製造共同构成。市场领导和创新新参与企业都在投资研发能够降低血栓形成反应的涂层化学技术、能够延长功能持续时间的膜材料以及能够提高批次间一致性的生产过程。设备设计方与临床研究中心之间的策略伙伴关係加速了实证医学证据的产生，而与契约製造製造商和包装专家的合作则有助于更快地扩大生产规模并拓展地域覆盖范围。

中空纤维几何结构、表面处理流程和整合感测器技术的智慧财产权组合仍然是战略资产，而那些将强大的智慧财产权保护与清晰的临床价值主张提案结合的公司往往能够获得有利的采购结果。销售策略各不相同，一些公司强调与医院建立直接联繫和进行临床培训项目，而另一些公司则利用分销商网络实现广泛应用。对于许多製药公司而言，下一波差异化浪潮将来自于展现强大的实际临床表现、提供综合临床支援服务以及在关键司法管辖区展现清晰的合规路径。

为高阶主管提供切实可行的优先行动方案，以加强供应链、加速材料创新、实现平台模组化并深化临床伙伴关係，进而推动永续应用。

产业领导者必须在多个方面采取行动，以赢得临床信任、保障净利率并确保供应的连续性。首先，应优先考虑供应商多元化和尽可能选择近岸外包，以降低进口关税和物流波动带来的风险。其次，应加快对聚甲基戊烯加工能力和有效表面处理技术的投资，以显着降低血液相容性风险。第三，应在产品系列设计中融入模组化概念，使同一核心氧气浓缩机平台能够满足不同的应用场景，例如冠状动脉冠状动脉绕道手术移植术、瓣膜置换术、静脉-动脉体外膜氧合（VA-ECMO）和静脉体外膜肺氧合（VECMO）。

此外，我们将透过结构化的培训计画和以结果为导向的支援服务，扩大临床参与度，以减少在门诊手术中心和社区医院实施过程中遇到的阻力。我们将积极与监管机构沟通，使临床证据的产生与核准途径保持一致，并预测无菌性和标籤要求的变化。最后，在贸易政策和报销预期不断变化的环境下，我们将透过强调与采购方进行透明的整体使用成本沟通，并着重于设备的可靠性、生命週期物流和上市后支持，来建立长期的采购关係。

技术和商业性洞察透过严谨的多模态调查方法检验，该方法结合了专家访谈、临床文献综述、法规分析和供应商分析。

该调查方法基于多层级研究方法，旨在确保研究结果的可重复性、临床有效性和商业性适用性。主要研究内容包括对临床医生、灌注师、采购专业人员和生产负责人进行结构化访谈，以了解实际应用中的性能预期、采购限制和营运考虑。次要研究整合了同行评审的临床文献、监管文件、设备标籤、专利系列和标准指南，以检验技术声明并建立基准性能标准。供应商分布图和生产能力评估结合了公共资源、行业名录和现场讯息，以确定产能限制和区域生产布局。

此分析方法着重于三角验证，即从临床洞察中解读技术规范，并将其与生产可行性和监管先例进行配对。細項分析利用检验的临床工作流程和采购行为，将定性需求驱动因素分配给设备类型、应用、终端用户、材料、流程配置和温度通讯协定。其局限性包括各国采购惯例的差异和不断变化的贸易政策，调查方法透过基于情境的敏感性检查和专家检验来解决这些问题。访谈过程中遵循了伦理审查程序和保密措施，以保护专有临床数据并确保符合研究管治规范。

整合临床、技术、监管和供应链优先事项的策略结论，指导膜氧气疗法领域做出具有韧性、以临床为中心的决策。

最后，膜式氧合器处于临床表现、材料工程和供应链策略的关键交汇点。设计选择，特别是膜结构、聚合物选择和表面化学的选择，直接影响心肺体外迴圈、体外膜氧合和研究应用的临床结果。监管预期、临床中心分散化和新兴贸易政策的相互作用，要求相关人员采取灵活的筹资策略、有针对性的临床证据产生和产品模组化设计，以保持竞争力。

决策者应优先考虑兼顾材料创新和可製造性的投资，同时重视临床医师使用便利性和上市后监测。区域策略应根据当前的监管和采购环境进行调整，而那些兼具卓越技术能力和服务交付能力的公司将更有利于获得长期的临床认可。透过整合本文概述的策略、临床和营运方面的见解，产业参与者可以应对短期挑战，同时推进更安全、更有效的氧气输送解决方案，造福病患。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 开发生物活性肝素结合聚合物膜以降低体外生命维持中的血栓形成风险
  • 整合即时感测器阵列和人工智慧驱动的分析技术，用于预测薄膜性能
  • 用于现场急救的携带式体外循环装置和膜式氧合器的微型化
  • 利用3D列印技术製备聚甲基戊烯膜以实现客製化流动动力学的研究进展
  • 监管协调旨在使长期体外膜氧合（ECMO）设备能够支持患者数週的治疗。
  • 儿科专用低预充氧合器设计的出现旨在最大限度减少新生儿护理中的血液稀释
  • 利用释放一氧化氮的聚合物实现无肝素表面涂层，以提高生物相容性

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 膜式氧合器市场（按类型划分）

  • 平板
  • 中空纤维

9. 按应用分類的薄膜式氧合器市场

  • 血液氧合研究
    • 动物实验
    • 体外研究
  • 心肺体外迴圈
    • 冠状动脉绕道手术手术
    • 瓣膜置换手术
  • 体外膜氧合器
    • 静脉-动脉体外膜氧合（ECMO）
    • 静脉体外膜氧合（ECMO）

第十章 依最终用户分類的薄膜式氧合器市场

  • 门诊手术中心
  • 医院
  • 研究所

第十一章 膜式氧合器市场（依材料划分）

  • 聚甲基戊烯
  • 聚丙烯
  • 聚砜

第十二章 依流量组合分類的薄膜式氧合器市场

  • 封闭式
  • 打开

第十三章 依温度分類的薄膜式氧合器市场

  • 低温
  • 正常体温

第十四章 膜式氧合器市场（依地区分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 膜式氧合器市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国膜式氧合器市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Getinge AB
    • Medtronic PLC
    • LivaNova PLC
    • Terumo Corporation
    • Fresenius Medical Care AG & Co. KGaA
    • Merck KGaA
    • Nipro Corporation
    • Asahi Kasei Medical Co., Ltd.
    • Xenios AG
    • Nikkiso Co., Ltd.
Product Code: MRR-3E7F10ED1B0D

The Membrane Oxygenators Market is projected to grow by USD 1,114.33 million at a CAGR of 6.77% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 659.81 million
Estimated Year [2025] USD 704.16 million
Forecast Year [2032] USD 1,114.33 million
CAGR (%) 6.77%

A comprehensive orientation to membrane oxygenators that frames clinical imperatives, technological underpinnings, regulatory pressures, and strategic priorities for industry stakeholders

Membrane oxygenators are a foundational technology in extracorporeal life support and surgical perfusion, serving as the blood-gas exchange interface that sustains oxygenation and carbon dioxide removal during cardiopulmonary bypass procedures and prolonged extracorporeal membrane oxygenation. Their design, materials, and integration with monitoring systems determine not only clinical performance but also disposability, biocompatibility, and ease of use in high-acuity settings. As clinical practice evolves toward more complex critical care applications and ambulatory surgical interventions, oxygenator reliability and predictability remain pivotal to patient outcomes.

Increasingly, clinicians demand devices that balance physiologic performance with operational efficiency. This has driven parallel developments in membrane geometry, fiber fabrication, and surface chemistry to reduce hemolysis, complement activation, and thrombogenicity while maintaining low transmembrane pressure gradients. At the same time, regulatory expectations for single-use devices, sterilization validation, and human factors engineering have sharpened product development priorities. Taken together, these technical and clinical drivers frame the remainder of this executive summary and set the stage for strategic decisions across manufacturing, procurement, and clinical adoption.

How material innovations, device miniaturization, digital integration, and decentralized clinical practice are redefining design, manufacturing, and procurement standards in membrane oxygenation

The membrane oxygenator landscape has undergone transformative shifts driven by clinical need, materials science, and systems integration. Hollow fiber architectures, coupled with advanced polymethylpentene membranes and refined surface coatings, have largely supplanted earlier flat sheet approaches for high-performance extracorporeal support, yielding improvements in gas transfer efficiency and hemocompatibility. Parallel advances in manufacturing fidelity and sterilization processes have enabled scaled production of single-use oxygenators that meet stringent sterility and traceability expectations, while also simplifying operating room logistics.

Concurrently, the clinical environment for these devices is decentralizing. Increased use of extracorporeal membrane oxygenation in nontraditional settings, expansion of ambulatory surgical centers performing complex procedures, and greater reliance on simulation and point-of-care diagnostics have shifted demand toward more modular, user-friendly devices with integrated monitoring. Digital health integration-including real-time sensor telemetry and decision-support algorithms-has enhanced clinician ability to titrate therapy and preempt complications. Sustainability has emerged as a secondary yet growing priority, prompting manufacturers to evaluate lifecycle impacts and to explore recyclable packaging, reduced material footprints, and production waste reduction. Together, these shifts are reshaping development roadmaps, go-to-market strategies, and the criteria by which purchasers evaluate product value.

Analyzing the cumulative supply chain, procurement, and innovation consequences of United States tariff adjustments anticipated in 2025 for membrane oxygenator stakeholders

Anticipated trade policy changes and tariff adjustments in the United States during 2025 carry important implications for membrane oxygenator supply chains, procurement strategies, and price dynamics. Many oxygenator components and high-precision manufacturing inputs originate in cross-border supply chains, and increased duties on imported raw materials, polymer resins, or finished components may elevate landed costs for manufacturers and downstream purchasers. This shift tends to incentivize both suppliers and OEMs to reassess sourcing strategies, accelerate supplier qualification for domestic or nearshore partners, and consider localized inventory buffers to maintain continuity of supply under fluctuating trade conditions.

The cumulative effect of tariff-driven cost pressures often manifests through slower new product introductions and more conservative inventory management in the near term, as manufacturers prioritize margin protection and supply stability. In response, several mitigation pathways are practicable: diversifying the supplier base to reduce single-source exposure; qualifying alternate materials that preserve clinical performance while improving tariff treatment; and implementing contract manufacturing agreements in tariff-favored jurisdictions. For purchasers, longer procurement lead times and revised total-cost-of-ownership calculations will require renewed emphasis on supplier transparency and collaborative forecasting. Ultimately, trade policy is accelerating strategic decisions around vertical integration, supplier partnerships, and design choices that can reduce vulnerability to import duties while sustaining clinical performance standards.

Segmentation-driven insights that reveal how device architecture, clinical application, end-user priorities, material science, flow configuration, and thermal protocols intersect to inform product strategy

Insightful segmentation clarifies how product features, clinical use cases, and organizational purchasing priorities intersect to shape demand and innovation pathways. Based on Type, the market is studied across Flat Sheet and Hollow Fiber architectures; flat sheet designs retain niche applicability for certain bench research and specialized low-flow scenarios, while hollow fiber constructs dominate clinical extracorporeal applications where surface-area-to-volume efficiency and compact form factor matter. In application contexts, the market is studied across Blood Oxygenation For Research, Cardiopulmonary Bypass, and Extracorporeal Membrane Oxygenation. Blood Oxygenation For Research is further studied across Animal Studies and In Vitro Studies, which drive material testing and preclinical performance validation; Cardiopulmonary Bypass is further studied across Coronary Artery Bypass Grafting and Valve Replacement Surgery, both of which impose distinct perfusion time profiles and anticoagulation management challenges; and Extracorporeal Membrane Oxygenation is further studied across Venoarterial ECMO and Venovenous ECMO, reflecting divergent hemodynamic and oxygenation requirements that influence membrane selection and flow architecture.

End user segmentation reveals differing procurement drivers: Ambulatory Surgical Centers, Hospitals, and Research Institutes each evaluate oxygenators through lenses of cost efficiency, clinical robustness, and experimental flexibility, respectively. Based on Material, the market is studied across Polymethylpentene, Polypropylene, and Polysulfone, with polymethylpentene increasingly preferred for long-duration extracorporeal support due to its favorable gas permeability and thermal stability, while polypropylene offers cost advantages in some disposable formats and polysulfone provides broad thermal and chemical resilience. Flow configuration analysis, based on Flow Configuration, examines Closed and Open systems, where closed-loop designs prioritize infection control and precise gas exchange control and open configurations favor simplicity and accessibility for certain surgical workflows. Temperature-driven segmentation, based on Temperature, studies Hypothermic and Normothermic use cases, recognizing that membrane performance and hemocompatibility profiles can differ under altered thermal states and that device validation must address biophysical variability across these clinical protocols. Collectively, these segmentation lenses inform design trade-offs, regulatory strategies, and targeted commercialization approaches.

Regional clinical adoption, regulatory diversity, and manufacturing capacity shape differentiated strategies across the Americas, EMEA, and Asia-Pacific markets for membrane oxygenator businesses

Regional variation influences clinical practices, regulatory pathways, and procurement frameworks in ways that matter for manufacturers and health systems alike. In the Americas, clinical adoption is shaped by concentrated centers of excellence for extracorporeal therapy, a regulatory environment that emphasizes post-market surveillance and device traceability, and supply chains that favor both domestic manufacturing and strategic imports. These dynamics create opportunities for companies that can demonstrate robust clinical data, scalable manufacturing, and responsive service models.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with country-specific procurement norms; reimbursement variability and divergent hospital tender processes require flexible commercialization models and strong clinical affairs engagement. Local manufacturing partnerships and distributor relationships frequently determine market entry speed. Asia-Pacific continues to exhibit rapid clinical adoption in selected urban centers, coupled with an expanding base of local manufacturers and contract producers capable of competing on lead time and cost. Strategic partnerships, technology transfer agreements, and region-specific regulatory strategies are essential to navigate this diverse territory and to align product portfolios with regional clinical and economic priorities.

Competitive and partnership dynamics that highlight material innovation, IP positioning, manufacturing scaling, and service-enabled differentiation among membrane oxygenator providers

Competitive dynamics in the membrane oxygenator landscape are defined by a blend of specialized manufacturers, large medical device OEMs, and nimble contract producers. Market leaders and innovative newcomers alike are investing in coating chemistries that reduce thrombogenic response, in membrane materials that extend functional duration, and in manufacturing processes that improve lot-to-lot consistency. Strategic partnerships between device designers and clinical research centers are accelerating evidence generation, while alliances with contract manufacturers and packaging specialists are enabling faster scale-up and broader geographic reach.

Intellectual property portfolios around hollow fiber geometry, surface treatment processes, and integrated sensor technologies remain strategic assets, and companies that combine strong IP protection with a clear clinical value proposition tend to secure favorable procurement outcomes. Distribution strategies vary, with some firms emphasizing direct hospital relationships and clinical training programs, while others leverage distributor networks to broaden penetration. For many players, the next wave of differentiation will come from demonstrating superior real-world performance, offering integrated clinical support services, and presenting clear pathways for regulatory compliance in key jurisdictions.

Practical and prioritized actions for executives to fortify supply chains, accelerate material innovation, modularize platforms, and deepen clinical partnerships to drive sustainable adoption

Industry leaders must adopt a multi-pronged set of actions to capture clinical trust, protect margins, and ensure supply continuity. First, prioritize supplier diversification and nearshoring where feasible to reduce exposure to import duties and logistics volatility; dual-sourcing critical inputs and qualifying alternate polymer suppliers will materially improve resilience. Second, accelerate investment in polymethylpentene processing capabilities and in validated surface treatments that demonstrably reduce hemocompatibility risks, since these attributes increasingly inform purchasing decisions among perfusionists and critical care teams. Third, design product portfolios with modularity in mind, enabling the same core oxygenator platform to address distinct use cases-such as coronary artery bypass grafting, valve replacement surgery, venoarterial ECMO, and venovenous ECMO-through targeted configurators and accessory kits.

Additionally, expand clinical engagement through structured training programs and outcome-oriented support services that reduce adoption friction in ambulatory surgical centers and community hospitals. Engage proactively with regulatory bodies to align clinical evidence generation with approval pathways and to anticipate changes in sterility and labeling requirements. Finally, adopt transparent total-cost-of-use communication with purchasers, emphasizing device reliability, lifecycle logistics, and post-market support to build durable procurement relationships in an environment of evolving trade policy and reimbursement expectations.

A rigorous multimodal research methodology combining expert interviews, clinical literature review, regulatory analysis, and supplier mapping to validate technical and commercial insights

This research draws on a layered methodology designed to ensure reproducibility, clinical relevance, and commercial applicability. Primary inputs include structured interviews with clinicians, perfusionists, procurement professionals, and manufacturing leaders to capture real-world performance expectations, procurement constraints, and operational considerations. Secondary research synthesizes peer-reviewed clinical literature, regulatory filings, device labeling, patent families, and standards guidance to validate technological claims and to establish baseline performance criteria. Supplier mapping and manufacturing capability assessments combine public filings, industry directories, and site-level intelligence to identify capacity constraints and regional production footprints.

Analytical methods emphasize triangulation: clinical insights inform interpretation of technical specifications, which are then cross-checked against manufacturing feasibility and regulatory precedent. Segmentation analysis uses validated clinical workflows and procurement behaviors to allocate qualitative demand drivers across device types, applications, end users, materials, flow configurations, and temperature protocols. Limitations include variability in country-level procurement practices and the evolving nature of trade policy, which the methodology addresses through scenario-based sensitivity checks and expert validation rounds. Ethical review procedures and confidentiality safeguards were applied during interviews to protect proprietary clinical data and to ensure compliance with research governance norms.

Strategic conclusions synthesizing clinical, technical, regulatory, and supply chain priorities to guide resilient and clinically focused decision-making in membrane oxygenation

In closing, membrane oxygenators occupy a critical nexus of clinical performance, materials engineering, and supply chain strategy. Design choices-particularly around membrane architecture, polymer selection, and surface chemistry-directly influence clinical outcomes across cardiopulmonary bypass, extracorporeal membrane oxygenation, and research applications. The interplay between regulatory expectations, decentralizing clinical settings, and emergent trade policies requires stakeholders to pursue resilient sourcing strategies, targeted clinical evidence generation, and product modularity to remain competitive.

Decision-makers should prioritize investments that align material innovation with manufacturability, while maintaining a sharp focus on clinician usability and post-market surveillance. Regional strategies must be tailored to prevailing regulatory and procurement landscapes, and companies that combine technical excellence with service-enabled offerings will be better positioned to capture long-term clinical trust. By integrating the strategic, clinical, and operational insights outlined here, industry participants can navigate near-term disruptions while advancing safer, more effective oxygenation solutions for patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of bioactive heparin-bonded polymer membranes to reduce clotting risk in extracorporeal life support
  • 5.2. Integration of real-time sensor arrays and AI-driven analytics for predictive membrane performance monitoring
  • 5.3. Miniaturization of portable extracorporeal membrane oxygenators for in-field emergency applications
  • 5.4. Advancements in polymethylpentene membrane manufacturing using 3D printing for customized flow dynamics
  • 5.5. Regulatory alignment for extended duration ECMO devices supporting multi-week patient therapies
  • 5.6. Emergence of pediatric-specific low-prime oxygenator designs to minimize hemodilution in neonatal care
  • 5.7. Implementation of heparin-free surface coatings utilizing nitric oxide-releasing polymers to enhance biocompatibility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Membrane Oxygenators Market, by Type

  • 8.1. Flat Sheet
  • 8.2. Hollow Fiber

9. Membrane Oxygenators Market, by Application

  • 9.1. Blood Oxygenation For Research
    • 9.1.1. Animal Studies
    • 9.1.2. In Vitro Studies
  • 9.2. Cardiopulmonary Bypass
    • 9.2.1. Coronary Artery Bypass Grafting
    • 9.2.2. Valve Replacement Surgery
  • 9.3. Extracorporeal Membrane Oxygenation
    • 9.3.1. Venoarterial ECMO
    • 9.3.2. Venovenous ECMO

10. Membrane Oxygenators Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Research Institutes

11. Membrane Oxygenators Market, by Material

  • 11.1. Polymethylpentene
  • 11.2. Polypropylene
  • 11.3. Polysulfone

12. Membrane Oxygenators Market, by Flow Configuration

  • 12.1. Closed
  • 12.2. Open

13. Membrane Oxygenators Market, by Temperature

  • 13.1. Hypothermic
  • 13.2. Normothermic

14. Membrane Oxygenators Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Membrane Oxygenators Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Membrane Oxygenators Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Getinge AB
    • 17.3.2. Medtronic PLC
    • 17.3.3. LivaNova PLC
    • 17.3.4. Terumo Corporation
    • 17.3.5. Fresenius Medical Care AG & Co. KGaA
    • 17.3.6. Merck KGaA
    • 17.3.7. Nipro Corporation
    • 17.3.8. Asahi Kasei Medical Co., Ltd.
    • 17.3.9. Xenios AG
    • 17.3.10. Nikkiso Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. MEMBRANE OXYGENATORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. MEMBRANE OXYGENATORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEMBRANE OXYGENATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN MEMB